Skip to main content
Laurence Corash, MD, Hematology, San Francisco, CA

Laurence M. Corash MD


Physician

Join to View Full Profile
  • 505 Parnassus AveSan Francisco, CA 94143

  • Phone+1 415-353-1672

  • Fax+1 415-353-1804

Dr. Corash is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Internal Medicine, 1969 - 1971
  • New York University School of Medicine
    New York University School of MedicineClass of 1969

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1982 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Hematology
    American Board of Pathology Hematology

Publications & Presentations

PubMed

Abstracts/Posters

  • Impact of Amotosalen/UVA Pathogen Inactivated Platelet Components on Outcomes after Allogeneic Hematopoetic Stem Cell Transplantation: A Single Center Analysis
    Laurence Corash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • A Sequential Cohort Study of Pathogen Reduced Platelet Component Transfusion without Use of Leukocyte Reduction for Hematopoietic Stem Cell Transplant (HSCT): Impact o... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury
    Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic InjuryJuly 21st, 2025
  • Cerus Corporation Celebrates World Blood Donor Day 2021
    Cerus Corporation Celebrates World Blood Donor Day 2021June 14th, 2021
  • Cerus Corporation Announces Presentation of Study Results with INTERCEPT-Treated COVID-19 Convalescent Plasma at the American Society of Hematology Annual Meeting
    Cerus Corporation Announces Presentation of Study Results with INTERCEPT-Treated COVID-19 Convalescent Plasma at the American Society of Hematology Annual MeetingDecember 4th, 2020

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: